10x Genomics (TXG) Cash from Financing Activities (2018 - 2026)
10x Genomics (TXG) posted Cash from Financing Activities of -$8.4 million for Q1 2026, down 475.42% sequentially from $2.2 million in Q4 2025, and down 2094.55% YoY from $422000.0 in Q1 2025.
10x Genomics (TXG) Cash from Financing Activities (2018 - 2026) Analysis & Trends
10x Genomics has reported Cash from Financing Activities for 9 years, with the latest figure at -$8.4 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 2094.55% year-over-year to -$8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 120.99% YoY) and the FY2025 annual result came in at $6.8 million, down 37.67% from the prior year.
- Cash from Financing Activities declined to -$8.4 million in Q1 2026 per TXG's latest filing, from $2.2 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $7.1 million in Q2 2023 and troughed at -$8.4 million in Q1 2026.
- A 5-year average of $2.3 million and a median of $2.4 million in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities soared 295.51% in 2025, then sank 2094.55% in 2026.
- Over 5 years, Cash from Financing Activities stood at $5.0 million in 2022, then increased by 12.24% to $5.6 million in 2023, then fell by 19.53% to $4.5 million in 2024, then sank by 50.37% to $2.2 million in 2025, then sank by 475.42% to -$8.4 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$8.4 million, $2.2 million, and $617000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -354.13 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -137.18 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 3.02 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | -30.48 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 512.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -7.10 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | -100.55 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.02 Mn |
| Jun 30, 2026 | 3.02 Mn |
| Mar 31, 2026 | -8.42 Mn |
| Mar 31, 2026 | -8.42 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 617,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 422,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Dec 31, 2024 | 4.52 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Sep 30, 2024 | 156,000.00 |
| Sep 30, 2024 | 156,000.00 |
| Jun 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.64 Mn |